Net shares · 90d
-156.5K
0 buy · 156.5K sell
Net value · 90d
-$10.0M
$0 in · $10.0M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
11
0 buy · 156.5K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 90d
-
ORKA Sell·S
Director · 10b5-1
$2.5M
35.0K sh · $70.13 avg · 2 lots
Own -47%
-
APGE Sell·S
Chief Medical Officer · 10b5-1
$432.9K
5.5K sh · $78.71
Own -3%
-
ORKA Sell·S
Director · 10b5-1
$6.2M
105.0K sh · $58.97 avg · 3 lots
Own -59%
-
APGE Sell·S
Chief Medical Officer · 10b5-1
$462.8K
5.5K sh · $84.14 avg · 2 lots
Own -3%
-
APGE Sell·S
Chief Medical Officer · 10b5-1
$466.6K
5.5K sh · $84.84 avg · 3 lots
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | ORKA | Sell S | 35.0K2 lots | $2.5M |
| Jun 3, 2026 | APGE | Sell S | 5.5K | $432.9K |
| May 21, 2026 | ORKA | Sell S | 105.0K3 lots | $6.2M |
| May 6, 2026 | APGE | Sell S | 5.5K2 lots | $462.8K |
| Apr 1, 2026 | APGE | Sell S | 5.5K3 lots | $466.6K |
Buy Sell Non-market (grant · exercise · gift)
About Dambkowski Carl
This profile aggregates every SEC Form 4 insider transaction reported by Dambkowski Carl across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.